store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Simotinib (AL-6802) is a selective and orally bioactive EGFR tyrosine kinase inhibitor (IC50: 19.9 nM) with anti-tumour activity for the study of non-small cell lung cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,080.00 | |
50 mg | 8-10 weeks | $ 1,410.00 | |
100 mg | 8-10 weeks | $ 1,990.00 |
Description | Simotinib (AL-6802) is a selective and orally bioactive EGFR tyrosine kinase inhibitor (IC50: 19.9 nM) with anti-tumour activity for the study of non-small cell lung cancer. |
Targets&IC50 | EGFR:19.9 nM |
In vitro | In vitro studies have shown that sunitinib inhibits the growth of EGFR and EGFR-overexpressing human A431 tumor cells in a dose-dependent manner, with no significant activity against other kinases examined in the study[1]. |
In vivo | Multiple doses of sunitinib reduced rat body weight by decreasing food intake, similar to human patients, indicating adverse effects of sunitinib on the gastrointestinal tract[2]. |
Synonyms | AL-6802, SIM-6802 |
Molecular Weight | 500.95 |
Formula | C25H26ClFN4O4 |
CAS No. | 944258-89-3 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (199.60 mM), when pH is adjusted to 3 with HCl. Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Simotinib 944258-89-3 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR AL-6802 SIM-6802 inhibitor inhibit